Andere talen Infant Bacterial Therapeutics AB

Aandelen

IBT B

SE0008015259

Beurs gesloten - Nasdaq Stockholm Andere beurzen 17:22:34 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
87,8 ^SEK	+0,46%		+4,03%	-2,44%

08/02	Infant Bacterial Therapeutics AB (publ) rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
08/02	Infant Bacterial Therapeutics AB (publ) rapporteert winstresultaten voor het vierde kwartaal eindigend op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Infant Bacterial Therapeutics : Major Milestone Achieved - Last Patient Enrolled in Infant Bacterial Therapeutics' Phase 3 Study	04/04
Major Milestone Achieved - Last Patient Enrolled in Infant Bacterial Therapeutics’ Phase 3 Study	04/04
Notice of Annual General Meeting of Infant Bacterial Therapeutics	03/04
Infant Bacterial Therapeutics AB publishes the Annual Report for 2023	25/03
Infant Bacterial Therapeutics AB (publ), Interim report January 1-December 31, 2023	08/02
Infant Bacterial Therapeutics AB Reports Earnings Results for the Full Year Ended December 31, 2023	08/02
Infant Bacterial Therapeutics AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	08/02
Infant Bacterial Therapeutics AB (publ), Interim report January 1-September 30, 2023	10/11
Infant Bacterial Therapeutics AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	10/11
Infant Bacterial Therapeutics AB (publ) announces the appointment of the Nomination Committee for the Annual General Meeting 2024	24-10-23
Infant Bacterial Therapeutics AB Announces the Appointment of the Nomination Committee for the Annual General Meeting 2024	24-10-23
Infant Bacterial Therapeutics AB (publ) Interim report January 1 - June 30, 2023	25-08-23
Infant Bacterial Therapeutics AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	25-08-23
New number of shares and votes in IBT	31-07-23
New number of shares and votes in IBT	31-07-23
Additional Infant Bacterial Therapeutics product receives FDA orphan drug designation	04-07-23
Sweden’s Infant Bacterial Therapeutics to Raise SEK101 Million via Rights Issue	04-07-23
IBT announces outcome of its rights issue	04-07-23
Additional Infant Bacterial Therapeutics product receives FDA orphan drug designation	03-07-23
The futility analysis for IBT’s Connection Study positive	21-06-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Infant Bacterial Therapeutics AB

Aandelen

IBT B

SE0008015259

Andere talen

Filters